REMUNITYPRO FOR REMODULIN (TREPROSTINIL) INJECTION Trademark

Trademark Overview

On Thursday, June 13, 2024, a trademark application was filed for REMUNITYPRO FOR REMODULIN (TREPROSTINIL) INJECTION with the United States Patent and Trademark Office. The USPTO has given the REMUNITYPRO FOR REMODULIN (TREPROSTINIL) INJECTION trademark a serial number of 98598862. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 4, 2025. This trademark is owned by United Therapeutics Corporation. The REMUNITYPRO FOR REMODULIN (TREPROSTINIL) INJECTION trademark is filed in the Medical Instrument Products category with the following description:

Drug delivery systems, namely, pump injectors for the subcutaneous delivery of medication
remunitypro for remodulin (treprostinil) injection

General Information

Serial Number98598862
Word MarkREMUNITYPRO FOR REMODULIN (TREPROSTINIL) INJECTION
Filing DateThursday, June 13, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 4, 2025

Trademark Statements

Description of MarkThe mark consists of "REMUNITYPRO FOR REMODULIN (TREPROSTINIL) INJECTION" in stylized font to the right of three overlapping open circles formed by dots of varying sizes.
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"(TREPROSTINIL) INJECTION"
Goods and ServicesDrug delivery systems, namely, pump injectors for the subcutaneous delivery of medication

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, June 13, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUnited Therapeutics Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910
Party NameUnited Therapeutics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910

Trademark Events

Event DateEvent Description
Thursday, June 13, 2024NEW APPLICATION ENTERED
Thursday, January 2, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, January 3, 2025ASSIGNED TO EXAMINER
Monday, January 13, 2025ASSIGNED TO EXAMINER
Tuesday, January 14, 2025EXAMINER'S AMENDMENT ENTERED
Tuesday, January 14, 2025EXAMINERS AMENDMENT E-MAILED
Tuesday, January 14, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 14, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 14, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 14, 2025PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, January 14, 2025EXAMINER'S AMENDMENT ENTERED
Tuesday, January 14, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 14, 2025EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 14, 2025EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 14, 2025EXAMINERS AMENDMENT E-MAILED
Wednesday, January 29, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 4, 2025PUBLISHED FOR OPPOSITION
Tuesday, February 4, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, January 2, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

injection treprostinil remodulin remunitypro delivery subcutaneous medication injectors namely systems drug pump